Martinez M.S.,Laboratorio 3 Of Genetica Y Diagnostico Molecular |
Ramirez Bello J.,Laboratorio 4 Of Histocompatibilidad
Gaceta Medica de Mexico | Year: 2013
Cardiovascular diseases are a major public health problem globally. In 1997, cardiovascular disease caused 41% of deaths in the United States. It has been reported that about 60 million people in the United States have some form of cardiovascular disease. These entities are chronic conditions initiated by a dysregulation of the immune response. One gene and its protein producttumor necrosis factor α(TNF-α)-a powerful pleiotropic cytokine with multiple cellular functions, plays a role in the inflammation, initiation, development, susceptibility, severity, and response to treatment, etc. of coronary artery disease (CAD). The focus of the present review is to summarize recent evidence showing the biological role of TNF-αin the initiation and progression of endothelial dysfunction and complications of atherosclerosis, and as a genetic variation of TNF-αconfer susceptibility, severity, and treatment response in CAD: ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction, unstable angina, and coronary restenosis.